Latest news
Here you can find news items and blogs by Pancreatic Cancer UK staff and guest writers
Birmingham scientists develop first-of-its-kind ‘ChemoPatch’ to stop pancreatic cancer returning
Researchers at the University of Birmingham have been awarded £87,000 by our organisation to develop a new device which will deliver chemotherapy directly to tissue left behind after surgery reducing the likelihood of the cancer recurring.
Research Involvement Network: Jay’s story
Jay is a member of our Research Involvement Network (RIN). In this blog, Jay breaks down what the researchers have been working on and the conversations she had at our annual Discovery and Translational Research Forum.
Gene ‘switched off’ in early stages of pancreatic cancer, allowing rapid tumour growth and spread
The findings of a research project that we part-funded from Nottingham Trent University has now been announced, with researchers discovering that pancreatic cancer is able to 'switch off' a gene which enables it to become more aggressive.
General election: what happens next
Last week’s election has delivered a new Government, and a seismic shift in UK politics. Looking ahead to this Parliament, there are big opportunities to make progress on pancreatic and other less survivable cancers.
General election manifesto round-up
Our Head of Influencing and Health Improvement, Alfie Bailey-Bearfield, shares a manifesto round-up.
Demanding Survival at Downing Street
Last week we handed in our open letter, signed by over 63,000 Pancreatic Cancer UK supporters who backed our Demand Survival Now manifesto.
A day in the life working on the support line
Nicci is one of our specialist nurses. This is an example of a day in the life working on the support line.
Our response to the PERT shortages
Find out more about the PERT shortages, what we're doing in response and how we can support you if you're affected.
Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer
Research funded by us has uncovered a more effective way of identifying people with new-onset diabetes who are also at higher risk of developing pancreatic cancer than current recommendations set out by The National Institute for Health and Care Excellence (NICE).
How we’re striving for better treatments
Thanks to our generous supporters, we’ve invested £14.4 million in research into the early detection and treatment of pancreatic cancer to date.
Pancreatic Cancer UK announced as 2025 TCS London Marathon official charity of the year
Pancreatic Cancer UK is the official charity of the year for the 2025 TCS London Marathon, so "take on the ultimate test to help develop the ultimate test”
We’re making some changes
We’re excited to announce that we’re making some changes to how we look and the way we talk about our vital work.